Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
03/21/2012 | EP2151241B1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
03/21/2012 | EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis |
03/21/2012 | EP1478399B1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
03/21/2012 | EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS |
03/21/2012 | EP1436624B1 A method of diagnosis and treatment and agents useful for same |
03/21/2012 | CN202169020U 合并小肠经、肺经两组织疾病的治疗装置 Treatment of the small intestine by means merger, the two organizations lung disease |
03/21/2012 | CN1441770B Modified forms of pharmacologically active agents and uses therefor |
03/21/2012 | CN102388066A Antibody molecules having binding specificity for human IL-13 |
03/21/2012 | CN102388039A Pyrazole derivatives used as CCR4 receptor antagonists |
03/21/2012 | CN102382172A Binding agents which inhibit myostatin |
03/21/2012 | CN102382113A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
03/21/2012 | CN102380101A Pholcodine-containing compound pharmaceutical preparation for treating cold |
03/21/2012 | CN102380087A Chinese medicinal composition for treating cough and dyspnea |
03/21/2012 | CN102380085A Veterinary-use compound medication composition for fever abatement and respiratory tract infection resistance |
03/21/2012 | CN102380075A Chinese medicine for treating child respiratory system infection and inflammation |
03/21/2012 | CN102380061A Chinese medicinal composition for eliminating and dissolving phlegm and relieving cough, as well as preparation method and application thereof |
03/21/2012 | CN102380037A Traditional Chinese medicine for treating chronic prostatitis |
03/21/2012 | CN102380035A Common coltsfoot flower, dwarf lilyturf tuber, white mulberry root-bark, ginkgo seed, whiteflower hogfennel root, elaeagnus pungens and Chinese wolfberry root-bark decoction for treating bronchial asthma |
03/21/2012 | CN102380034A Preparation of composition containing sesquiterpene glucoside and flavonoid components |
03/21/2012 | CN102380028A Medicament for treating child antiadoncus |
03/21/2012 | CN102380027A Traditional Chinese medicine composition for treating bronchitis |
03/21/2012 | CN102380025A Preparation method of fritillary bulb cough syrup |
03/21/2012 | CN102380019A Preparation method of traditional Chinese medicinal lotion for treating turbid phlegm stagnation bedsore |
03/21/2012 | CN102380006A Traditional Chinese medicine composition for treating upper respiratory tract infection |
03/21/2012 | CN102379959A Traditional Chinese herbal composite for curing rhinitis |
03/21/2012 | CN102379958A Chinese medicinal preparation for resisting bacteria, diminishing inflammation, eliminating phlegm and relieving cough and preparation method thereof |
03/21/2012 | CN102379946A Orally-taking traditional Chinese medicine for treating pharyngitis |
03/21/2012 | CN102379942A Traditional Chinese medicine for treating pneumonia |
03/21/2012 | CN102379927A Preparation methods of poppy shell extract and cough tablet |
03/21/2012 | CN102379926A Traditional Chinese medicine composition for treating viral influenza |
03/21/2012 | CN102379915A Olive effervescent tablet and preparation method thereof |
03/21/2012 | CN102379908A Wall breaking method for fresh and live ganoderma lucidum spores |
03/21/2012 | CN102379907A Ganoderma lucidum double vitamin methionine preparation and production method thereof |
03/21/2012 | CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
03/21/2012 | CN102379866A Pharmaceutical composition and process |
03/21/2012 | CN102379846A Fluticasone propionate aerosol preparation with hydrofluoroalkane and polyethylene glycol as auxiliary materials |
03/21/2012 | CN102379830A Chinese herbal medicine toothpaste |
03/21/2012 | CN102166319B Soup for treating wind cold |
03/21/2012 | CN102166280B Chinese medicinal composition for preventing and treating common cold and influenza and preparation method thereof |
03/21/2012 | CN102079750B Cefuroxime sodium compound and new preparation method thereof |
03/21/2012 | CN101940760B Traditional Chinese medicine for treating chronic tracheitis |
03/21/2012 | CN101822678B Cefamandole nafate combined drug |
03/21/2012 | CN101757074B Chewable tablet prepared from berberis |
03/21/2012 | CN101744782B Tablet containing faropenem sodium |
03/21/2012 | CN101721706B Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application |
03/21/2012 | CN101703572B Method for preparing Chinese medicinal composition for treating respiratory disease of livestock and application thereof |
03/21/2012 | CN101606989B Novel preparation method of trollius chinensis granular preparation |
03/21/2012 | CN101491515B Use of paclitaxel in preparing medicine for preventing and treating idiopathic pulmonary fibrosis |
03/21/2012 | CN101490009B Synthesis of acylaminoalkenylene amides useful as substance P antagonists. |
03/21/2012 | CN101432009B Preventative treatment and remission of allergic diseases |
03/21/2012 | CN101184725B N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
03/21/2012 | CN101130071B Vaccine |
03/21/2012 | CN101015519B Loratadine oral compound medication composition |
03/21/2012 | CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
03/20/2012 | US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
03/20/2012 | US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
03/20/2012 | US8138311 Modified proteins, designer toxins, and methods of making thereof |
03/20/2012 | US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease. |
03/20/2012 | US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta |
03/20/2012 | US8138172 8-oxoadenine derivatives acting as modulators of TLR7 |
03/20/2012 | US8138141 HMG1 antibody for treating inflammatory conditions |
03/20/2012 | CA2676907C Tricyclic compounds and their use as glucocorticoid receptor modulators |
03/20/2012 | CA2514507C Methods and compositions for the treatment of gastrointestinal disorders |
03/20/2012 | CA2456721C Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders |
03/20/2012 | CA2446872C Immune-modulating peptide |
03/20/2012 | CA2406206C Improvements in or relating to formulations for use in inhaler devices |
03/20/2012 | CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
03/20/2012 | CA2363067C Compounds and methods to inhibit or augment an inflammatory response |
03/20/2012 | CA2351580C Stabilization of macrolides |
03/15/2012 | WO2012033941A1 Methods for concomitant treatment of theophylline and febuxostat |
03/15/2012 | WO2012033789A2 Treatment of diseases |
03/15/2012 | WO2012033348A2 Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol |
03/15/2012 | WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds |
03/15/2012 | WO2012032067A1 Polymorphs and salts of n- [5- [4- (5- { [(2r,6s) -2, 6 - dimethyl - 4 -morpholinyl] methyl} - 1, 3 - oxazol - 2 - yl) - 1h- inda zol-6-yl] -2- (methyloxy) - 3 - pyridinyl] methanesulfonamide |
03/15/2012 | WO2012031979A1 Nasal spray |
03/15/2012 | WO2012031603A2 Airway administration of angiogenesis inhibitors |
03/15/2012 | WO2012031466A1 2-(p-octylphenylethyl)-2-amino propanediol derivatives and uses thereof |
03/15/2012 | WO2012031445A1 Processes for preparing piperazinium salts of kmup and use thereof |
03/15/2012 | WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
03/15/2012 | US20120065573 Methods of Treating Vascular Lesions |
03/15/2012 | US20120065249 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
03/15/2012 | US20120065236 Methods for concomitant treatment of theophylline and febuxostat |
03/15/2012 | US20120065226 Salts of tiotropium with 10-camphorsulfonic acid |
03/15/2012 | US20120065223 Solid forms of a chemokine receptor antagonist and methods of use thereof |
03/15/2012 | US20120065214 Compounds and their uses 708 |
03/15/2012 | US20120065207 Methods for concomitant treatment of theophylline and febuxostat |
03/15/2012 | US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
03/15/2012 | US20120065191 Pharmaceutical compounds |
03/15/2012 | US20120065189 Heterocyclic compounds for the treatment of stress-related conditions |
03/15/2012 | US20120065187 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
03/15/2012 | US20120065185 Substituted alkylamine derivatives and methods of use |
03/15/2012 | US20120065184 Compounds and compositions as trk inhibitors |
03/15/2012 | US20120065177 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
03/15/2012 | US20120065174 Compositions of glycopyrronium salt for inhalation |
03/15/2012 | US20120065173 Chemical compounds |
03/15/2012 | US20120065167 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response |
03/15/2012 | US20120065165 Compositions and methods of treating endothelial disorders |
03/15/2012 | US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis |
03/15/2012 | US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
03/15/2012 | US20120064179 Bicarbonate solution for bioavailable magnesium and uses thereof |